Literature DB >> 27752727

A nanomechanical study of the effects of colistin on the Klebsiella pneumoniae AJ218 capsule.

Anna Mularski1, Jonathan Wilksch2, Eric Hanssen3, Jian Li4, Takehiro Tomita5, Sacha James Pidot2, Tim Stinear2, Frances Separovic6, Dick Strugnell2.   

Abstract

Atomic force microscopy measurements of capsule thickness revealed that that the wild-type Klebsiella pneumoniae AJ218 capsular polysaccharides were rearranged by exposure to colistin. The increase in capsule thickness measured near minimum inhibitory/bactericidal concentration (MIC/MBC) is consistent with the idea that colistin displaces the divalent cations that cross-bridge adjacent lipopolysaccharide (LPS) molecules through the capsule network. Cryo-electron microscopy demonstrated that the measured capsule thickness at near MIC/MBC of 1.2 μM was inflated by the disrupted outer membrane, through which the capsule is excreted and LPS is bound. Since wild-type and capsule-deficient strains of K. pneumoniae AJ218 have equivalent MICs and MBCs, the presence of the capsule appeared to confer no protection against colistin in AJ218. A spontaneously arising colistin mutant showed a tenfold increase in resistance to colistin; genetic analysis identified a single amino acid substitution (Q95P) in the PmrB sensor kinase in this colistin-resistant K. pneumoniae AJ218. Modification of the lipid A component of the LPS could result in a reduction of the net-negative charge of the outer membrane, which could hinder binding of colistin to the outer membrane and displacement of the divalent cations that bridge adjacent LPS molecules throughout the capsular polysaccharide network. Retention of the cross-linking divalent cations may explain why measurements of capsule thickness did not change significantly in the colistin-resistant strain after colistin exposure. These results contrast with those for other K. pneumoniae strains that suggest that the capsule confers colistin resistance.

Entities:  

Keywords:  Antimicrobial peptide; Atomic force microscopy; Capsular polysaccharide; Colistin; Klebsiella pneumoniae; Polymyxin

Mesh:

Substances:

Year:  2016        PMID: 27752727     DOI: 10.1007/s00249-016-1178-2

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   1.733


  43 in total

1.  Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa.

Authors:  L Zhang; P Dhillon; H Yan; S Farmer; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

2.  Seroepidemiology of Klebsiella pneumoniae in an Australian Tertiary Hospital and its implications for vaccine development.

Authors:  Adam W Jenney; Abigail Clements; Jacinta L Farn; Odilia L Wijburg; Andrew McGlinchey; Denis W Spelman; Tyrone L Pitt; Mary E Kaufmann; Lisa Liolios; Margaret B Moloney; Steven L Wesselingh; Richard A Strugnell
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

3.  Spatially resolved force spectroscopy of bacterial surfaces using force-volume imaging.

Authors:  Fabien Gaboriaud; Bhargava S Parcha; Michelle L Gee; James A Holden; Richard A Strugnell
Journal:  Colloids Surf B Biointerfaces       Date:  2007-10-09       Impact factor: 5.268

4.  Cationic peptide-induced remodelling of model membranes: direct visualization by in situ atomic force microscopy.

Authors:  James E Shaw; Raquel F Epand; Jenny C Y Hsu; Gary C H Mo; Richard M Epand; Christopher M Yip
Journal:  J Struct Biol       Date:  2007-11-17       Impact factor: 2.867

5.  The bacteria fight back.

Authors:  Gary Taubes
Journal:  Science       Date:  2008-07-18       Impact factor: 47.728

6.  Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria.

Authors:  V de Lorenzo; M Herrero; U Jakubzik; K N Timmis
Journal:  J Bacteriol       Date:  1990-11       Impact factor: 3.490

7.  New method for quantitative determination of uronic acids.

Authors:  N Blumenkrantz; G Asboe-Hansen
Journal:  Anal Biochem       Date:  1973-08       Impact factor: 3.365

8.  Contribution of the Klebsiella pneumoniae capsule to bacterial aggregate and biofilm microstructures.

Authors:  Stephen P Dzul; Margaret M Thornton; Danial N Hohne; Elizabeth J Stewart; Aayush A Shah; David M Bortz; Michael J Solomon; John G Younger
Journal:  Appl Environ Microbiol       Date:  2011-01-14       Impact factor: 4.792

9.  Unravelling of a mechanism of resistance to colistin in Klebsiella pneumoniae using atomic force microscopy.

Authors:  C Formosa; M Herold; C Vidaillac; R E Duval; E Dague
Journal:  J Antimicrob Chemother       Date:  2015-05-27       Impact factor: 5.790

10.  Bacteria survive multiple puncturings of their cell walls.

Authors:  Zhiyong Suo; Recep Avci; Muhammedin Deliorman; Xinghong Yang; David W Pascual
Journal:  Langmuir       Date:  2009-04-21       Impact factor: 3.882

View more
  3 in total

1.  Molecular prevalence of resistance determinants, virulence factors and capsular serotypes among colistin resistance carbapenemase producing Klebsiella pneumoniae: a multi-centric retrospective study.

Authors:  Aradhana Das; Rajesh Kumar Sahoo; Mahendra Gaur; Suchanda Dey; Saubhagini Sahoo; Anshuman Sahu; Dibyajyoti Uttameswar Behera; Sangita Dixit; Pooja Singhvi Jain; Bhawana Jain; Kundan Kumar Sahu; K Swapna Kumari; Enketeswara Subudhi
Journal:  3 Biotech       Date:  2021-12-28       Impact factor: 2.406

2.  LPS O Antigen Plays a Key Role in Klebsiella pneumoniae Capsule Retention.

Authors:  Shweta Singh; Jonathan J Wilksch; Rhys A Dunstan; Anna Mularski; Nancy Wang; Dianna Hocking; Leila Jebeli; Hanwei Cao; Abigail Clements; Adam W J Jenney; Trevor Lithgow; Richard A Strugnell
Journal:  Microbiol Spectr       Date:  2022-08-01

Review 3.  MgrB Mutations and Altered Cell Permeability in Colistin Resistance in Klebsiella pneumoniae.

Authors:  Polly Soo-Xi Yap; Wan-Hee Cheng; Sook-Keng Chang; Swee-Hua Erin Lim; Kok-Song Lai
Journal:  Cells       Date:  2022-09-26       Impact factor: 7.666

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.